Literature DB >> 32958939

Metabolic and epigenetic regulation of T-cell exhaustion.

Fabien Franco1,2, Alison Jaccard1,2, Pedro Romero1,2, Yi-Ru Yu3,4, Ping-Chih Ho5,6.   

Abstract

Current immunotherapies yield remarkable clinical outcomes by boosting the power of host immunity in cancer cell elimination and viral clearance. However, after prolonged antigen exposure, CD8+ T cells differentiate into a special differentiation state known as T-cell exhaustion, which poses one of the major hurdles to antiviral and antitumor immunity during chronic viral infection and tumour development. Growing evidence indicates that exhausted T cells undergo metabolic insufficiency with altered signalling cascades and epigenetic landscapes, which dampen effector immunity and cause poor responsiveness to immune-checkpoint-blockade therapies. How metabolic stress affects T-cell exhaustion remains unclear; therefore, in this Review, we summarize current knowledge of how T-cell exhaustion occurs, and discuss how metabolic insufficiency and prolonged stress responses may affect signalling cascades and epigenetic reprogramming, thus locking T cells into an exhausted state via specialized differentiation programming.

Entities:  

Mesh:

Year:  2020        PMID: 32958939     DOI: 10.1038/s42255-020-00280-9

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  145 in total

Review 1.  Metabolic coordination of T cell quiescence and activation.

Authors:  Nicole M Chapman; Mark R Boothby; Hongbo Chi
Journal:  Nat Rev Immunol       Date:  2019-08-12       Impact factor: 53.106

2.  T Cell Exhaustion: An Epigenetically Imprinted Phenotypic and Functional Makeover.

Authors:  Francesca Alfei; Dietmar Zehn
Journal:  Trends Mol Med       Date:  2017-08-07       Impact factor: 11.951

Review 3.  Fueling immunity: insights into metabolism and lymphocyte function.

Authors:  Erika L Pearce; Maya C Poffenberger; Chih-Hao Chang; Russell G Jones
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

4.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development.

Authors:  Gerritje J W van der Windt; Bart Everts; Chih-Hao Chang; Jonathan D Curtis; Tori C Freitas; Eyal Amiel; Edward J Pearce; Erika L Pearce
Journal:  Immunity       Date:  2011-12-28       Impact factor: 31.745

Review 5.  Metabolic Instruction of Immunity.

Authors:  Michael D Buck; Ryan T Sowell; Susan M Kaech; Erika L Pearce
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

6.  Posttranscriptional control of T cell effector function by aerobic glycolysis.

Authors:  Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

7.  Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand.

Authors:  Daniel E Bauer; Marian H Harris; David R Plas; Julian J Lum; Peter S Hammerman; Jeffrey C Rathmell; James L Riley; Craig B Thompson
Journal:  FASEB J       Date:  2004-06-04       Impact factor: 5.191

8.  Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.

Authors:  Michael D Buck; David O'Sullivan; Ramon I Klein Geltink; Jonathan D Curtis; Chih-Hao Chang; David E Sanin; Jing Qiu; Oliver Kretz; Daniel Braas; Gerritje J W van der Windt; Qiongyu Chen; Stanley Ching-Cheng Huang; Christina M O'Neill; Brian T Edelson; Edward J Pearce; Hiromi Sesaki; Tobias B Huber; Angelika S Rambold; Erika L Pearce
Journal:  Cell       Date:  2016-06-09       Impact factor: 41.582

Review 9.  Transcriptional control of effector and memory CD8+ T cell differentiation.

Authors:  Susan M Kaech; Weiguo Cui
Journal:  Nat Rev Immunol       Date:  2012-10-19       Impact factor: 53.106

10.  Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.

Authors:  Ping-Chih Ho; Jessica Dauz Bihuniak; Andrew N Macintyre; Matthew Staron; Xiaojing Liu; Robert Amezquita; Yao-Chen Tsui; Guoliang Cui; Goran Micevic; Jose C Perales; Steven H Kleinstein; E Dale Abel; Karl L Insogna; Stefan Feske; Jason W Locasale; Marcus W Bosenberg; Jeffrey C Rathmell; Susan M Kaech
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

View more
  49 in total

1.  Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics.

Authors:  Qi Liu; Fangming Zhu; Xinnan Liu; Ying Lu; Ke Yao; Na Tian; Lingfeng Tong; David A Figge; Xiuwen Wang; Yichao Han; Yakui Li; Yemin Zhu; Lei Hu; Yingning Ji; Nannan Xu; Dan Li; Xiaochuan Gu; Rui Liang; Guifang Gan; Lifang Wu; Ping Zhang; Tianle Xu; Hui Hu; Zeping Hu; Huji Xu; Dan Ye; Hui Yang; Bin Li; Xuemei Tong
Journal:  Nat Metab       Date:  2022-05-23

2.  Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Zixuan Zhang; Yuta Hasegawa; Daigo Hashimoto; Hajime Senjo; Ryo Kikuchi; Xuanzhong Chen; Kazuki Yoneda; Tomoko Sekiguchi; Tatsuya Kawase; Hirofumi Tsuzuki; Takashi Ishio; Takahide Ara; Hiroyuki Ohigashi; Masao Nakagawa; Takanori Teshima
Journal:  Bone Marrow Transplant       Date:  2022-02-28       Impact factor: 5.483

3.  Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.

Authors:  Giselle M Boukhaled; Ramy Gadalla; Heidi J Elsaesser; Diala Abd-Rabbo; Rene Quevedo; S Y Cindy Yang; Mengdi Guo; Ben X Wang; Babak Noamani; Diana Gray; Sally C M Lau; Kirsty Taylor; Kyaw Aung; Anna Spreafico; Aaron R Hansen; Samuel D Saibil; Naoto Hirano; Cynthia Guidos; Trevor J Pugh; Tracy L McGaha; Pamela S Ohashi; Adrian G Sacher; Marcus O Butler; David G Brooks
Journal:  Nat Immunol       Date:  2022-07-14       Impact factor: 31.250

4.  CRISPR Screens to Identify Regulators of Tumor Immunity.

Authors:  Martin W LaFleur; Arlene H Sharpe
Journal:  Annu Rev Cancer Biol       Date:  2021-12-23

5.  Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model.

Authors:  Alireza Mardomi; Marzieh Ghollasi; Mohsen Korani; Mahsa Panahi; Mohammad Parsa-Kondelaji; Mehdi Sabzichi; Ali Salimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-09-09       Impact factor: 3.195

Review 6.  Metabolic communication in the tumour-immune microenvironment.

Authors:  Kung-Chi Kao; Stefania Vilbois; Chin-Hsien Tsai; Ping-Chih Ho
Journal:  Nat Cell Biol       Date:  2022-10-13       Impact factor: 28.213

Review 7.  Clinical implications of T cell exhaustion for cancer immunotherapy.

Authors:  Andrew Chow; Karlo Perica; Christopher A Klebanoff; Jedd D Wolchok
Journal:  Nat Rev Clin Oncol       Date:  2022-10-10       Impact factor: 65.011

Review 8.  Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy.

Authors:  Mengjiao Zhou; Minjian Yuan; Meng Zhang; Chenyi Lei; Omer Aras; Xiaohong Zhang; Feifei An
Journal:  Eur J Med Chem       Date:  2021-09-04       Impact factor: 7.088

Review 9.  A guide to interrogating immunometabolism.

Authors:  Kelsey Voss; Hanna S Hong; Jackie E Bader; Ayaka Sugiura; Costas A Lyssiotis; Jeffrey C Rathmell
Journal:  Nat Rev Immunol       Date:  2021-04-15       Impact factor: 108.555

Review 10.  Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy.

Authors:  Farhad Dastmalchi; Loic P Deleyrolle; Aida Karachi; Duane A Mitchell; Maryam Rahman
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.